Atlas Trials

Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

Clinical trial NCT02015208 · COMPLETED

Trial details

NCT number
NCT02015208
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2014-04-01
Primary completion
2015-07-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.